Wei‐Yun Lai

1.5k total citations
29 papers, 1.1k citations indexed

About

Wei‐Yun Lai is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wei‐Yun Lai has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wei‐Yun Lai's work include Cancer, Hypoxia, and Metabolism (6 papers), Neuroblastoma Research and Treatments (6 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Wei‐Yun Lai is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Neuroblastoma Research and Treatments (6 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Wei‐Yun Lai collaborates with scholars based in Taiwan, Sweden and Belgium. Wei‐Yun Lai's co-authors include Pan‐Chyr Yang, Hung-Wen Tsai, Hsing‐Wen Sung, Yen Chang, Mei‐Chin Chen, Emily Lin, Shu‐Fen Peng, Ming‐You Shie, Fwu‐Long Mi and Tsung‐Rong Kuo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Wei‐Yun Lai

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Yun Lai Taiwan 18 500 287 208 167 141 29 1.1k
Lu Han China 17 550 1.1× 353 1.2× 277 1.3× 244 1.5× 106 0.8× 50 1.2k
Michael J. Poellmann United States 20 280 0.6× 526 1.8× 214 1.0× 155 0.9× 61 0.4× 46 1.0k
Jayanta Bhattacharyya India 18 513 1.0× 338 1.2× 539 2.6× 147 0.9× 90 0.6× 60 1.3k
Xiaopan Cai China 17 491 1.0× 572 2.0× 384 1.8× 226 1.4× 198 1.4× 35 1.2k
Kyung Eun Lee South Korea 20 500 1.0× 365 1.3× 271 1.3× 105 0.6× 116 0.8× 34 1.0k
Lingyong Jiang China 19 605 1.2× 563 2.0× 230 1.1× 204 1.2× 149 1.1× 52 1.5k
Manuela Rizzi Italy 20 490 1.0× 217 0.8× 140 0.7× 115 0.7× 143 1.0× 67 1.5k
Junyi Che China 19 393 0.8× 389 1.4× 270 1.3× 76 0.5× 94 0.7× 38 1.1k
Shilei Ni China 21 302 0.6× 421 1.5× 351 1.7× 94 0.6× 122 0.9× 55 1.2k
Bo Qiu China 20 424 0.8× 134 0.5× 118 0.6× 186 1.1× 162 1.1× 59 1.3k

Countries citing papers authored by Wei‐Yun Lai

Since Specialization
Citations

This map shows the geographic impact of Wei‐Yun Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Yun Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Yun Lai more than expected).

Fields of papers citing papers by Wei‐Yun Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Yun Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Yun Lai. The network helps show where Wei‐Yun Lai may publish in the future.

Co-authorship network of co-authors of Wei‐Yun Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Yun Lai. A scholar is included among the top collaborators of Wei‐Yun Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Yun Lai. Wei‐Yun Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lai, Wei‐Yun, et al.. (2024). Anaplastic Lymphoma Kinase signaling stabilizes SLC3A2 expression via MARCH11 to promote neuroblastoma cell growth. Cell Death and Differentiation. 31(7). 910–923. 6 indexed citations
2.
Lai, Wei‐Yun, et al.. (2024). AptBCis1, An Aptamer–Cisplatin Conjugate, Is Effective in Lung Cancer Leptomeningeal Carcinomatosis. ACS Nano. 18(41). 27905–27916. 8 indexed citations
3.
Lai, Wei‐Yun, Ganesh Umapathy, Bengt Bergman, et al.. (2023). ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression. Proceedings of the National Academy of Sciences. 120(8). e2216479120–e2216479120. 15 indexed citations
4.
Lai, Wei‐Yun, et al.. (2023). Abstract 3544: ALK signaling activity stabilizes SLC3A2 protein levels in neuroblastoma tumorigenesis. Cancer Research. 83(7_Supplement). 3544–3544.
5.
Umapathy, Ganesh, Wei‐Yun Lai, Jikui Guan, et al.. (2023). ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences. 121(1). e2315242121–e2315242121. 6 indexed citations
6.
Lai, Wei‐Yun, Anh T. Le, Susanne Fransson, et al.. (2022). Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC. Lung Cancer. 171. 103–114. 7 indexed citations
7.
Lai, Wei‐Yun, et al.. (2021). PINK1-Mediated Inhibition of EGFR Dimerization and Activation Impedes EGFR-Driven Lung Tumorigenesis. Cancer Research. 81(7). 1745–1757. 1 indexed citations
8.
Umapathy, Ganesh, Wei‐Yun Lai, Barbara Witek, et al.. (2021). ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation. The EMBO Journal. 40(3). e105784–e105784. 33 indexed citations
9.
Javanmardi, Niloufar, Jimmy Van den Eynden, Susanne Fransson, et al.. (2020). 11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma. Cell Reports. 32(12). 108171–108171. 28 indexed citations
10.
Lai, Wei‐Yun, et al.. (2019). A Novel TNF-α-Targeting Aptamer for TNF-α-Mediated Acute Lung Injury and Acute Liver Failure. Theranostics. 9(6). 1741–1751. 110 indexed citations
11.
Lai, Wei‐Yun, et al.. (2017). A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect. Molecular Therapy — Nucleic Acids. 8. 520–528. 55 indexed citations
12.
Lin, Ching-Wen, Shu‐Ping Wang, Yih‐Leong Chang, et al.. (2016). Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis. Nature Communications. 7(1). 13867–13867. 76 indexed citations
13.
Lai, Wei‐Yun, et al.. (2016). A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects. Molecular Therapy — Nucleic Acids. 5(12). e397–e397. 136 indexed citations
14.
Kuo, Tsung‐Rong, Wei‐Yun Lai, Pan‐Chyr Yang, et al.. (2015). Fluorescence-Guided Probes of Aptamer-Targeted Gold Nanoparticles with Computed Tomography Imaging Accesses for in Vivo Tumor Resection. Scientific Reports. 5(1). 15675–15675. 91 indexed citations
15.
Lai, Wei‐Yun, Chia‐Tze Kao, Chi-Jr Hung, Tsui‐Hsien Huang, & Ming‐You Shie. (2014). An evaluation of the inflammatory response of lipopolysaccharide-treated primary dental pulp cells with regard to calcium silicate-based cements. International Journal of Oral Science. 6(2). 94–98. 30 indexed citations
16.
Lai, Wei‐Yun, et al.. (2014). Synergistic inhibition of lung cancer cell invasion, tumor growth and angiogenesis using aptamer-siRNA chimeras. Biomaterials. 35(9). 2905–2914. 60 indexed citations
17.
Yeh, Kun‐Tu, Ting‐Yuan Liu, Jia‐Hong Wu, et al.. (2014). CSNK1E/CTNNB1 Are Synthetic Lethal To TP53 in Colorectal Cancer and Are Markers for Prognosis. Neoplasia. 16(5). 441–450. 21 indexed citations
18.
Lai, Wei‐Yun, Chi‐Yuan Chen, Shuenn‐Chen Yang, et al.. (2014). Overcoming EGFR T790M-based Tyrosine Kinase Inhibitor Resistance with an Allele-specific DNAzyme. Molecular Therapy — Nucleic Acids. 3. e150–e150. 3 indexed citations
19.
Chen, Mei‐Chin, Hung-Wen Tsai, Shu‐Fen Peng, et al.. (2009). A nanoscale drug-entrapment strategy for hydrogel-based systems for the delivery of poorly soluble drugs. Biomaterials. 30(11). 2102–2111. 67 indexed citations
20.
Chen, Mei‐Chin, Yen Chang, Wei‐Yun Lai, et al.. (2008). The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents. Biomaterials. 30(1). 79–88. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lu Han Breakdown of academic impact, for papers by Michael J. Poellmann Breakdown of academic impact, for papers by Jayanta Bhattacharyya Breakdown of academic impact, for papers by Xiaopan Cai Breakdown of academic impact, for papers by Kyung Eun Lee Breakdown of academic impact, for papers by Lingyong Jiang Breakdown of academic impact, for papers by Manuela Rizzi Breakdown of academic impact, for papers by Junyi Che Breakdown of academic impact, for papers by Shilei Ni Breakdown of academic impact, for papers by Bo Qiu
Rankless by CCL
2026